{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T18:28:06Z","timestamp":1771698486698,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s10620-005-9062-4","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T18:14:58Z","timestamp":1146075298000},"page":"844-850","source":"Crossref","is-referenced-by-count":49,"title":["A Multicenter, Randomized, Double-Blind, 8-Week Comparative Trial of Standard Doses of Esomeprazole (40 mg) and Omeprazole (20\u00a0mg) for the Treatment of Erosive Esophagitis"],"prefix":"10.1007","volume":"51","author":[{"given":"Colleen","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Lightdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Hamelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"issue":"Suppl 1","key":"9062_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000200911","volume":"51","author":"SJ Spechler","year":"1992","unstructured":"Spechler SJ (1992) Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 51(Suppl 1):24\u201329","journal-title":"Digestion"},{"key":"9062_CR2","first-page":"326","volume":"14","author":"A Rai","year":"1998","unstructured":"Rai A, Orlando R (1998) Gastroesophageal reflux disease. Curr Opin Gastroenterol 14:326\u2013333","journal-title":"Curr Opin Gastroenterol"},{"issue":"8","key":"9062_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1155\/1998\/925346","volume":"12","author":"AB Thomson","year":"1998","unstructured":"Thomson AB, Chiba N, Armstrong D, Tougas G, Hunt RH (1998) The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving forward to new concepts. Can J Gastroenterol 12(8):551\u2013556","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"9062_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/gut.38.5.649","volume":"38","author":"RH Holloway","year":"1996","unstructured":"Holloway RH, Dent J, Narielvala F, Mackinnon AM (1996) Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis [see comments]. Gut 38(5):649\u2013654","journal-title":"Gut"},{"issue":"Suppl 4","key":"9062_CR5","first-page":"3s","volume":"92","author":"RC Orlando","year":"1997","unstructured":"Orlando RC (1997) The pathogenesis of gastroesophageal reflux disease: The relationship between epithelial defense, dysmotility, and acid exposure. Am J Gastroenterol 92(Suppl 4):3s\u20137s","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"9062_CR6","first-page":"577","volume":"7","author":"JW Freston","year":"1995","unstructured":"Freston JW, Malagelada JR, Petersen H, McCloy RF (1995) Critical issues in the management of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 7(6):577\u2013586","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl B","key":"9062_CR7","first-page":"66B","volume":"11","author":"N Chiba","year":"1997","unstructured":"Chiba N (1997) Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol 11(Suppl B):66B\u201373B","journal-title":"Can J Gastroenterol"},{"issue":"6","key":"9062_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003088-200140060-00003","volume":"40","author":"T Andersson","year":"2001","unstructured":"Andersson T, Hassan-Alin M, Hasselgren G, R\u00f3hss K, Weidolf W (2001) Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharmacokinet 40(6):411\u2013426","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"9062_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.1996.v111.pm8698230","volume":"111","author":"D Armstrong","year":"1996","unstructured":"Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1996) The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 111(1):85\u201392","journal-title":"Gastroenterology"},{"issue":"2","key":"9062_CR10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","volume":"45","author":"LR Lundell","year":"1999","unstructured":"Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1999) Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 45(2):172\u2013180","journal-title":"Gut"},{"issue":"Suppl 2","key":"9062_CR11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.44.2008.S1","volume":"44","author":"J Dent","year":"1999","unstructured":"Dent J, Brun J, Fendrick, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ, on behalf of the Genval Workshop Group (1999) An evidence-based appraisal of reflux disease management\u2014The Genval Workshop report. Gut 44(Suppl 2):S1\u2013S16","journal-title":"Gut"},{"issue":"10","key":"9062_CR12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2000.00856.x","volume":"14","author":"PJ Kahrilas","year":"2000","unstructured":"Kahrilas PJ, Falk GW, Johnson DA, Schmitt C, Collins DW, Whipple J, D\u2019Amico D, Hamelin B, Joelsson B, for the Esomeprazole Study Investigators (2000) Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: A randomized controlled trial. Aliment Pharmacol Ther 14(10):1249\u20131258","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"9062_CR13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1572-0241.2001.03600.x","volume":"96","author":"JE Richter","year":"2001","unstructured":"Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter J, Hwang C, Marino V, Hamelin B, Levine J, for the Esomeprazole Study Investigators (2001) Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial. Am J Gastroenterol 96(3):656\u2013665","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"9062_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0016-5085(92)91790-B","volume":"102","author":"SJ Sontag","year":"1992","unstructured":"Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, McCullough A, Ippoliti AF, Richter JE, Ahtaridis G, McCallum R, Pambianco DJ, Vlahcevic RZ, Johnson DA, Collen MJ, Lyon DT, Humphries TJ, Cagliola A, Berman RS (1992) Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. Multicenter Study. Gastroenterology 102(1):109\u2013118","journal-title":"Gastroenterology"},{"issue":"6","key":"9062_CR15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.1995.tb00437.x","volume":"9","author":"R Corinaldesi","year":"1995","unstructured":"Corinaldesi R, Valentini M, Belaiche J, Colin R, Geldof H, Maier C (1995) Pantoprazole and omeprazole in the treatment of reflux oesophagitis: A European multicentre study. Aliment Pharmacol Ther 9(6):667\u2013671","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"9062_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2036.1999.00438.x","volume":"13","author":"CP Dekkers","year":"1999","unstructured":"Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ, and the European Rabeprazole Study Group (1999) Double-blind, placebo-controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. Aliment Pharmacol Ther 13(1):49\u201357","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"9062_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2036.2001.00904.x","volume":"15","author":"VK Sharma","year":"2001","unstructured":"Sharma VK, Leontiadis GI, Howden CW (2001) Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis. Aliment Pharmacol Ther 15(2):227\u2013231","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"9062_CR18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2036.2000.00813.x","volume":"14","author":"T Lind","year":"2000","unstructured":"Lind T, Rydberg L, Kyleb\u00e4ck A, Jonsson A, Andersson T, Hasselgren G, Holmberg J, R\u00f6hss K (2000) Esomeprazole provides improved acid control versus omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 14(7):861\u2013867","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"9062_CR19","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","volume":"98","author":"P Miner Jr","year":"2003","unstructured":"Miner P Jr, Katz PO, Chen Y, Sostek M (2003) Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 98(12):2616\u20132620","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"9062_CR20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1023\/A:1015009300955","volume":"47","author":"K R\u00f6hss","year":"2002","unstructured":"R\u00f6hss K, Hasselgren G, Hedenstr\u00f6m H (2002) Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci 47(5):954\u2013958","journal-title":"Dig Dis Sci"},{"issue":"4","key":"9062_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2036.2005.02339.x","volume":"21","author":"MB Fennerty","year":"2005","unstructured":"Fennerty MB, Johanson JF, Hwang C, Sostek M (2005) Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis. Aliment Pharmacol Ther 21(4):455\u2013463","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-9062-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-9062-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-9062-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:35:42Z","timestamp":1559230542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-9062-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,27]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["9062"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-9062-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,27]]}}}